STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 8 registered members and 96 guests viewing the site.

Sanofi-Aventis
Symbol: SNY-N
Active: Y
Sector: Pharma & Healthcare
Last Price: 34.100
Last Price Date: 2012-05-24 01:14:26
Globe 200 day average
Google Discussions (view only)
Yahoo Discussions (participate)


BUY	32.870	Charles Lannon	One of the largest and most popular drug companies in Europe. Has a strong product profile. French stocks, merely by their association, have been really hammered. Good stable business that will do well, irrespective of economic conditions. Good entry point.	2011-08-11

DON'T BUY	31.770	Karl Berger	PE of 8%. Might be a value trap. Not a lot of growth prospects. Vaccine business does fairly well. Pharma business is struggling a little and not much in the pipe at this point. (See Top Picks.)	2010-05-06

BUY	35.200	David Driscoll	Many of the health care stocks have started to recover or they are not down as much as the market this year. 4% yield and decent growth over time.	2008-07-04

BUY	42.090	David Burrows	Had as a toe-hold in the pharmaceutical group that has been out of favour for 3 years, but with only medium success. Facing competition from the generics. Has a great portfolio of drugs and has pretty steady growth.	2005-07-13

BUY	44.340	David Burrows	Pharmaceutical sector did very poorly over the last 2 years, but deceleration in revenue growth has slowed and profitability has started to improve. Look for the strongest perfoming stock in the sector. As Eli Lilly (LLY-N) is performing better, that would be the better of the 2, but would suggest you look at Sanofi-Aventis (SNY-N) which is close to new highs and Teva Pharmaceuticals (TEVA-Q) in generics.	2005-05-03